Efficacy of vatsnabhadi lepa in comparison with eusol in dushta vrana

Randomised controlled trial to evaluate efficasy of vatsnabhadi lepa in comparison with eusol in dushta vrana - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087933

Enrollment

Registered

2025-05-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T889- Complication of surgical and medical care, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having infected wound. Wound size 1 1 cm to 8 8cm. Infected wound due to trauma & accident with foul smell and pus discharge. Post- operative all infected wound. Diabetic Mellitus

Exclusion criteria

Exclusion criteria: Gangrenous wound. Neo-plastic ulcer. Burn, Arterial ulcer, Gout, Renal failure. Liver failure. Bed Sores. Varicose ulcer. HIV & Immuno-compromised patients

Design outcomes

Primary

Measure	Time frame
Treatment will continue till signs of shudhavrana are seen 3 weeksTimepoint: Treatment will continue till signs of shudhavrana are seen 3 weeks	—

Secondary

Measure	Time frame
To observe the duration required for achieving Shuddha Avastha To see the adverse effect of vatsnabhadi lepa dressing during the treatmentTimepoint: 15 to 20 days	—

Countries

India

Contacts

Public ContactDr Kalyani Anil Deshmukh

Mams Sumatibhai Shah Ayurved mahavidyalaya hadpsar Pune

khankhanemanohar@rediffmail.com8888763651

Outcome results